Answers are grounded in this paper and cite their sources.
FusionGDB has served diverse biological, health, and clinical research communities as a unique functional annotation knowledgebase of human fusion genes. In this study, we report an updated resource of human fusion gene annotation (FusionGDB 3.0), available at https://compbio.uth.edu/FusionGDB/. FusionGDB 3.0 includes substantial content updates: 156K up-to-date human fusion genes established by integrating 216K RNA-seq-based and 100K WGS-based breakpoint events, comprehensive open reading frame annotations, protein domain retention searches, and 1.13 million personalized fusion protein sequences reflecting individual nsSNVs from TCGA and CCLE, as well as N- and C-truncated protein sequences alongside canonical in-frame products. Furthermore, it incorporates 18K potential tumorigenic scenarios, supported by evidence from the literature, spanning drug-targetable gene group fusions, the epigenomic architecture around breakpoint junctions, and therapeutic prioritization scoring. FusionGDB 3.0 establishes a systematic framework for the functional annotation of coding structural variants. FusionGDB 3.0 serves as a pivotal reference knowledgebase for the genomics, oncology, and precision pharmacology communities, while also functioning as a foundational benchmark dataset for training and validating machine learning models, structural biology platforms, and AI-driven therapeutic discovery pipelines.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: